Naoyuki Matsumoto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Naoyuki Matsumoto has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Kazuo Komiyama
Department of Pathology, Nihon University School of Dentistry
5 shared publications - Masatake Asano
Department of Pathology, Nihon University School of Dentistry
2 shared publications Michisato Okudera
2 shared publicationsTaiichi Kitano
2 shared publicationsYasuyoshi Matsue
2 shared publications- Yoshinori Jinbu
Department of Dentistry, Oral and Maxillofacial Surgery, Jichi Medical University
2 shared publications
Latest Publications
- 1 April 2016
- Vol. 36 (4) , 1571-9
Rapid and Specific Screening Assay for KRAS Oncogene Mutation by a Novel Gene Amplification Method.
Epidermal growth factor receptor (EGFR) is a target of molecular therapeutics for colorectal cancer. However, mutation of Kirsten rat sarcoma viral oncogene homolog (KRAS) gene at codons 12 and 13 attenuates the therapeutic effect of anti-EGFR therapies. Therefore, the detection of KRAS gene mutation is important for therapeutic decision-making. KRAS gene mutation at codons 12 (c.34G>T, c.35G>C, c.35G>A) and 13 (c.38G>A) in six cancer cell lines were investigated. A loop-mediated isothermal amplification-based procedure was developed that employed peptide nucleic acid to suppress amplification of the wild-type allele. This mutation-oriented gene-amplification procedure can amplify the DNA fragment of the KRAS gene with codon 12 and codon 13 mutation within 30 min. Moreover, boiled cells can work as template resources. This newly developed procedure can be useful for patient stratification for anti-EGFR therapies.
- 1 April 2016
- Vol. 36 (4) , 1571-9
Rapid and Specific Screening Assay for KRAS Oncogene Mutation by a Novel Gene Amplification Method.
Epidermal growth factor receptor (EGFR) is a target of molecular therapeutics for colorectal cancer. However, mutation of Kirsten rat sarcoma viral oncogene homolog (KRAS) gene at codons 12 and 13 attenuates the therapeutic effect of anti-EGFR therapies. Therefore, the detection of KRAS gene mutation is important for therapeutic decision-making. KRAS gene mutation at codons 12 (c.34G>T, c.35G>C, c.35G>A) and 13 (c.38G>A) in six cancer cell lines were investigated. A loop-mediated isothermal amplification-based procedure was developed that employed peptide nucleic acid to suppress amplification of the wild-type allele. This mutation-oriented gene-amplification procedure can amplify the DNA fragment of the KRAS gene with codon 12 and codon 13 mutation within 30 min. Moreover, boiled cells can work as template resources. This newly developed procedure can be useful for patient stratification for anti-EGFR therapies.
- 1 January 2016
- Published by Nihon University School of Dentistry in Journal of Oral Science
- Vol. 58 (4) , 533-537
Diverse calcification patterns of ameloblastic fibro-odontoma on radiographic examination
The occurrence of ameloblastic fibro-odontoma (AFO) in the oral region is unusual and accounts for 1-3% of all odontogenic tumors. AFO presents mixed radiopaque patterns within the lesion with diverse findings; therefore, it is important to compare this tumor with other odontogenic tumors that radiographically present with calcified bodies. Herein, we observed the calcification patterns within the lesion in seven AFO cases (five males, two females; mean age, 8.3 years; age range, 4-13 years). Periapical and panoramic radiographs were obtained from all seven cases. Five cases underwent conventional computed tomography (CT) scanning, and one underwent cone beam CT. Classification of the calcifications primarily involved the following two characteristics on the X-rays: appearance and location of the lesions. All seven cases were located in the molar regions of the mandible in association with impacted teeth. The calcification patterns of these AFOs were mixed or inhomogeneous within the lesion with various findings, including complex odontoma-like calcifications. However, the patterns differed between panoramic radiography and CT in some cases. The radiolucent lesions in AFO demonstrated varying calcification patterns and were associated with impacted teeth on the CT images.(J Oral Sci 58, 533-537, 2016).
- 1 January 2016
- Published by Nihon University School of Dentistry in Journal of Oral Science
- Vol. 58 (4) , 533-537
Diverse calcification patterns of ameloblastic fibro-odontoma on radiographic examination
The occurrence of ameloblastic fibro-odontoma (AFO) in the oral region is unusual and accounts for 1-3% of all odontogenic tumors. AFO presents mixed radiopaque patterns within the lesion with diverse findings; therefore, it is important to compare this tumor with other odontogenic tumors that radiographically present with calcified bodies. Herein, we observed the calcification patterns within the lesion in seven AFO cases (five males, two females; mean age, 8.3 years; age range, 4-13 years). Periapical and panoramic radiographs were obtained from all seven cases. Five cases underwent conventional computed tomography (CT) scanning, and one underwent cone beam CT. Classification of the calcifications primarily involved the following two characteristics on the X-rays: appearance and location of the lesions. All seven cases were located in the molar regions of the mandible in association with impacted teeth. The calcification patterns of these AFOs were mixed or inhomogeneous within the lesion with various findings, including complex odontoma-like calcifications. However, the patterns differed between panoramic radiography and CT in some cases. The radiolucent lesions in AFO demonstrated varying calcification patterns and were associated with impacted teeth on the CT images.(J Oral Sci 58, 533-537, 2016).
- 1 January 2016
- Published by Japanese Society of Oral and Maxillofacial Surgeons in Japanese Journal of Oral and Maxillofacial Surgery
- Vol. 62 (11) , 561-565
A case of Hodgkin’s lymphoma arising in the maxillary gingiva
We report a case of Hodgkin’s lymphoma that involved the maxillary gingiva and bilateral cervical lymph nodes. The patient was an 89-year-old woman who complained about an ulcer in the right maxillary gingiva and swelling of the right cheek. Biopsy specimens taken from the gingiva showed typical Reed-Sternberg (RS) cells within a composite inflammatory milieu. Immunohistochemical analysis showed that the RS cells were positive for CD30, CD15, and CD20, and in situ hybridization analysis revealed that the cells were also positive for EBER1. Thus the disease was finally diagnosed as mixed cellularity Hodgkin’s lymphoma.
- 1 January 2016
- Published by Japanese Society of Oral and Maxillofacial Surgeons in Japanese Journal of Oral and Maxillofacial Surgery
- Vol. 62 (11) , 561-565
A case of Hodgkin’s lymphoma arising in the maxillary gingiva
We report a case of Hodgkin’s lymphoma that involved the maxillary gingiva and bilateral cervical lymph nodes. The patient was an 89-year-old woman who complained about an ulcer in the right maxillary gingiva and swelling of the right cheek. Biopsy specimens taken from the gingiva showed typical Reed-Sternberg (RS) cells within a composite inflammatory milieu. Immunohistochemical analysis showed that the RS cells were positive for CD30, CD15, and CD20, and in situ hybridization analysis revealed that the cells were also positive for EBER1. Thus the disease was finally diagnosed as mixed cellularity Hodgkin’s lymphoma.
- 1 March 2015
- Published by Elsevier in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
- Vol. 119 (3) , e138
Acinic Cell Carcinoma of the Parotid Gland. Fine Needle Aspiration Cytology Findings
- 1 March 2015
- Published by Elsevier in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
- Vol. 119 (3) , e138
Acinic Cell Carcinoma of the Parotid Gland. Fine Needle Aspiration Cytology Findings
- 1 January 2015
- Published by The Japanese Society of Oral Diagnosis/Oral Medicine in Japanese Journal of Oral Diagnosis / Oral Medicine
- Vol. 28 (3) , 202-207
A Case of Submandibular Lymphadenopathy with IgG4-related Disease
IgG4-related disease is a recently proposed pathological entity characterized by tumor-like enlargement of one or more organs, IgG4 positive plasma cell accumulation and raised serum IgG4 levels. We present a case of submandibular lymphadenopathy with IgG4-related disease. The patient was a 49-year-old man, who had been receiving periodontal treatment in our department. We investigated swelling of the right submandibular region that had been identified previously. An excisional biopsy revealed enlarged lymph nodes. IgG4 positive plasma cells were found in interfollicular areas (IgG4/IgG ratio: 89.5%). Thus, IgG4-related disease was suspected. The serum IgG4 level was high on blood testing, and so we consulted the department of rheumatology. At present, he is asymptomatic except for the head and neck lesions without medication. The patient is on regular follow-up with hematological and radiological examination.
- 1 January 2015
- Published by The Japanese Society of Oral Diagnosis/Oral Medicine in Japanese Journal of Oral Diagnosis / Oral Medicine
- Vol. 28 (3) , 202-207
A Case of Submandibular Lymphadenopathy with IgG4-related Disease
IgG4-related disease is a recently proposed pathological entity characterized by tumor-like enlargement of one or more organs, IgG4 positive plasma cell accumulation and raised serum IgG4 levels. We present a case of submandibular lymphadenopathy with IgG4-related disease. The patient was a 49-year-old man, who had been receiving periodontal treatment in our department. We investigated swelling of the right submandibular region that had been identified previously. An excisional biopsy revealed enlarged lymph nodes. IgG4 positive plasma cells were found in interfollicular areas (IgG4/IgG ratio: 89.5%). Thus, IgG4-related disease was suspected. The serum IgG4 level was high on blood testing, and so we consulted the department of rheumatology. At present, he is asymptomatic except for the head and neck lesions without medication. The patient is on regular follow-up with hematological and radiological examination.
- 1 April 2014
- Vol. 34 (4) , 1701-8
Sodium butyrate, a histone deacetylase inhibitor, regulates Lymphangiogenic factors in oral cancer cell line HSC-3.
Tumor angiogenesis is a focus of molecularly-targeted therapies. This study investigated the effect of sodium butyrate (SB), a histone deacetylase inhibitor, on the synthesis of antiangiogenic and lymphangiogenic factors in oral squamous cell carcinoma. Gene alterations in HSC-3 cells were assessed using cDNA microarrays before and after treatment with SB. The mRNA and protein expression of lymphangiogenic factors were also assessed by quantitative PCR, western blotting and immunocytochemistry. Microarray analysis revealed that treatment with SB led to altered expression of angiogenesis-related gene expression. The quantitative polymerase chain reaction showed that platelet-derived growth factor-B, angiopoietin-2, vascular endothelial growth factor (VEGF)-C, and VEGFD were down-regulated. Western blotting and immunocytochemistry confirmed reduced protein synthesis of VEGFC. SB inhibits expression of lymphangiogenic factors in HSC-3 cells. Within the limitations of the present study, SB may have potential as an anti-metastatic pro-drug for oral cancer.
- 1 April 2014
- Vol. 34 (4) , 1701-8
Sodium butyrate, a histone deacetylase inhibitor, regulates Lymphangiogenic factors in oral cancer cell line HSC-3.
Tumor angiogenesis is a focus of molecularly-targeted therapies. This study investigated the effect of sodium butyrate (SB), a histone deacetylase inhibitor, on the synthesis of antiangiogenic and lymphangiogenic factors in oral squamous cell carcinoma. Gene alterations in HSC-3 cells were assessed using cDNA microarrays before and after treatment with SB. The mRNA and protein expression of lymphangiogenic factors were also assessed by quantitative PCR, western blotting and immunocytochemistry. Microarray analysis revealed that treatment with SB led to altered expression of angiogenesis-related gene expression. The quantitative polymerase chain reaction showed that platelet-derived growth factor-B, angiopoietin-2, vascular endothelial growth factor (VEGF)-C, and VEGFD were down-regulated. Western blotting and immunocytochemistry confirmed reduced protein synthesis of VEGFC. SB inhibits expression of lymphangiogenic factors in HSC-3 cells. Within the limitations of the present study, SB may have potential as an anti-metastatic pro-drug for oral cancer.